Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Clinical trial NCT00054496 · UNKNOWN

Trial details

NCT number: NCT00054496
Sponsor: The Cleveland Clinic
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2002-08-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.